Cannabis Device Sensitivity Without Drug-Free Controls Could Not Establish Specificity
A saliva device can detect THC frequently in an exposure study while its false-positive rate remains unknown. A study of heavy cannabis users expressly did not establish specificity because it lacked an appropriate drug-free comparison.
Continuing users were deliberately selected
Twenty heavy cannabis users entered a crossover protocol involving cannabis with alcohol or alcohol placebo. Cannabis use on at least four days per week was an inclusion criterion. Participants could continue their normal cannabis routine, and baseline serum measurements could contain residual THC.
All active sessions included smoked THC at 400 micrograms/kg. Researchers collected serum and tested oral fluid repeatedly. Half the participants used the Dräger DrugTest 5000 and half the Securetec DrugWipe 5, so device comparisons were not paired within every individual.
Sensitivity varied by device and collection time
The DrugTest 5000 generally detected THC after the experimental smoking session, with reported sensitivity of 90–100% from fifteen minutes through three hours. The DrugWipe results were less sensitive over much of that interval. Manufacturer-stated thresholds differed, and the results concern the versions and protocol studied.
These detection findings should not be converted into “90–100% accurate for impairment.” The reference involved cannabinoid exposure, while the study’s field sobriety assessments addressed a separate behavioral question. Serum concentrations are also not interchangeable with whole-blood measurements.
Why a baseline sample is not necessarily a negative control
The authors stated that they did not determine false-positive rates because participants were not drug-free. A specimen taken before the scheduled dose can still contain residual drug. Such a baseline answers what was present before that session, not how often the device incorrectly labels genuinely reference-negative people.
Specificity requires suitable negative observations under a defined reference criterion. The study’s small sample, repeated measurements, residual exposure and different device groups restrict its scope. It supports a device- and time-specific detection comparison, while leaving broader false-positive and individual impairment claims unresolved.
Related: interpreting THC concentrations separately from impairment.
Primary research
A placebo-controlled study to assess Standardized Field Sobriety Tests performance during alcohol and cannabis intoxication in heavy cannabis users and accuracy of point of collection testing devices for detecting THC in oral fluid. DOI: 10.1007/s00213-012-2732-y.
